Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Age of diabetes diagnosis and lifetime risk of dementia: The Atherosclerosis Risk in Communities (ARIC) Study

View through CrossRef
<p dir="ltr">Objective The impact of age of diabetes diagnosis on dementia risk across the life course is poorly characterized. We estimated the lifetime risk of dementia by age of diabetes diagnosis. Research design and methods We included 13,087 participants from the Atherosclerosis Risk in Communities Study who were free from dementia at age 60 years. We categorized participants as having middle-age onset diabetes (diagnosis <60 years), older onset diabetes (diagnosis ≥ 60 years), or no diabetes. Incident dementia was ascertained via adjudication and active surveillance. We used the cumulative incidence function estimator to characterize the lifetime risk of dementia by age of diabetes diagnosis while accounting for the competing risk of mortality. We used restricted mean survival time to calculate years lived without and with dementia. Results Among 13,087 participants, there were 2,982 dementia cases and 4,662 deaths without dementia during a median follow-up of 24.1 (p25 17.4, p75 28.3) years. Persons with middle-age onset diabetes had a significantly higher lifetime risk of dementia than those with older onset diabetes (36.0% versus 31.0%). Compared to those with no diabetes, participants with middle-age onset diabetes also had a higher cumulative incidence of dementia by age 80 years (16.1% versus 9.4%), but a lower lifetime risk (36.0% versus 45.6%) due to shorter survival. Persons with middle-age onset diabetes developed dementia 4 and 1 years earlier than those without diabetes and those with older onset diabetes. Conclusions Preventing or delaying diabetes may be an important approach for reducing dementia risk throughout the life course.</p>
Title: Age of diabetes diagnosis and lifetime risk of dementia: The Atherosclerosis Risk in Communities (ARIC) Study
Description:
<p dir="ltr">Objective The impact of age of diabetes diagnosis on dementia risk across the life course is poorly characterized.
We estimated the lifetime risk of dementia by age of diabetes diagnosis.
Research design and methods We included 13,087 participants from the Atherosclerosis Risk in Communities Study who were free from dementia at age 60 years.
We categorized participants as having middle-age onset diabetes (diagnosis <60 years), older onset diabetes (diagnosis ≥ 60 years), or no diabetes.
Incident dementia was ascertained via adjudication and active surveillance.
We used the cumulative incidence function estimator to characterize the lifetime risk of dementia by age of diabetes diagnosis while accounting for the competing risk of mortality.
We used restricted mean survival time to calculate years lived without and with dementia.
Results Among 13,087 participants, there were 2,982 dementia cases and 4,662 deaths without dementia during a median follow-up of 24.
1 (p25 17.
4, p75 28.
3) years.
Persons with middle-age onset diabetes had a significantly higher lifetime risk of dementia than those with older onset diabetes (36.
0% versus 31.
0%).
Compared to those with no diabetes, participants with middle-age onset diabetes also had a higher cumulative incidence of dementia by age 80 years (16.
1% versus 9.
4%), but a lower lifetime risk (36.
0% versus 45.
6%) due to shorter survival.
Persons with middle-age onset diabetes developed dementia 4 and 1 years earlier than those without diabetes and those with older onset diabetes.
Conclusions Preventing or delaying diabetes may be an important approach for reducing dementia risk throughout the life course.
</p>.

Related Results

Age of diabetes diagnosis and lifetime risk of dementia: The Atherosclerosis Risk in Communities (ARIC) Study
Age of diabetes diagnosis and lifetime risk of dementia: The Atherosclerosis Risk in Communities (ARIC) Study
<p dir="ltr">Objective The impact of age of diabetes diagnosis on dementia risk across the life course is poorly characterized. We estimated the lifetime risk of dementia by ...
Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
AbstractIntroductionWe examined prevalence of mild cognitive impairment (MCI) and dementia in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive study.MethodsBeginning i...
Atherosclerosis and risk for dementia
Atherosclerosis and risk for dementia
AbstractObjectiveAtherosclerosis has been implicated in the development of dementia and its major subtypes, Alzheimer's disease and vascular dementia. However, support for this ass...
Burden of the Beast
Burden of the Beast
Introduction Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Understanding the knowledge and attitudes to dementia in Sub‐Saharan Africa: A systematic review
Understanding the knowledge and attitudes to dementia in Sub‐Saharan Africa: A systematic review
AbstractBackgroundA direct result of an ageing population is an increase in the prevalence of chronic non‐communicable diseases such as dementia. Creating dementia awareness and pr...
Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease
Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease
Background: Blacks have higher coronary heart disease (CHD) mortality compared with whites. However, a previous study suggests that nonfatal CHD risk may be lower for b...
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Diabetes mellitus (DM) has emerged as one of the most pressing public health challenges globally, and Pakistan stands among the countries most severely affected. With rising urbani...
Leveraging Clinical Notes and Natural Language Processing for Dementia Detection (Preprint)
Leveraging Clinical Notes and Natural Language Processing for Dementia Detection (Preprint)
BACKGROUND Routinely collected data (e.g. coded hospital data, clinical notes) are widely being used to develop dementia prevalence estimates. This is limit...

Back to Top